Compare ICMB & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICMB | MODD |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 33.0M |
| IPO Year | N/A | N/A |
| Metric | ICMB | MODD |
|---|---|---|
| Price | $2.70 | $0.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.8K | ★ 586.3K |
| Earning Date | 11-12-2025 | 02-12-2026 |
| Dividend Yield | ★ 19.26% | N/A |
| EPS Growth | ★ 31.51 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $17,931,778.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.75 | N/A |
| P/E Ratio | $7.04 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.46 | $0.28 |
| 52 Week High | $3.47 | $1.49 |
| Indicator | ICMB | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 47.14 |
| Support Level | $2.66 | $0.35 |
| Resistance Level | $2.73 | $0.41 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 18.18 | 60.85 |
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.